RAMM Pharma Corp.
RAMM
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 47.54% | 88.58% | 57.61% | -196.40% | 6.81% |
| Total Depreciation and Amortization | -50.92% | -31.58% | -26.44% | 23.58% | -14.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 95.49% | -733.69% | -102.71% | 284.00% | 31.47% |
| Change in Net Operating Assets | 144.93% | -35.63% | 4,346.67% | 3,116.35% | -216.44% |
| Cash from Operations | 79.34% | 56.25% | 79.31% | 54.42% | -71.37% |
| Capital Expenditure | -- | 17,700.00% | -83.33% | 58.55% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -122.94% | -124.14% |
| Cash from Investing | 349.66% | 1,957.61% | -154.66% | -124.36% | -163.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 70.74% | 16.41% | -11.90% | 7.54% | -23.88% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.38% | -- | -- | -25.68% | 31.71% |
| Cash from Financing | 62.35% | 37.55% | -6.24% | -4.43% | 63.95% |
| Foreign Exchange rate Adjustments | -158.33% | -396.83% | 206.00% | -91.63% | 132.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.62% | 122.06% | 74.09% | 44.15% | -47.96% |